TG Therapeutics
TGTX
TGTX
135 hedge funds and large institutions have $646M invested in TG Therapeutics in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding
Funds holding: 115 → 135 (+20)
7.39% more ownership
Funds ownership: 51.06% → 58.45% (+7.4%)
Holders
135
Holding in Top 10
2
Calls
$35.8M
Puts
$8.12M
Top Buyers
| 1 | +$60.3M | |
| 2 | +$33.3M | |
| 3 | +$11.9M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$11.1M |
| 5 |
Alkeon Capital Management
New York
|
+$11.1M |
Top Sellers
| 1 | -$49.1M | |
| 2 | -$10.2M | |
| 3 | -$5.98M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.61M |
| 5 |
BM
Bridger Management
New York
|
-$4.74M |